ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • Clin Pharmacol Biopharm,

Emerging Therapeutics in Cardiovascular Pharmacology: A Focus on Personalized Antihypertensive Strategies

Farzaneh Firoozbakht*
Institute for Computational Systems Biology, University of Hamburg, Germany
*Corresponding Author : Farzaneh Firoozbakht, Institute for Computational Systems Biology, University of Hamburg, Germany, Email: farzaneh232@gmail.com

Received Date: May 01, 2025 / Published Date: May 30, 2025

Abstract

   

Citation: Farzaneh F (2025) Emerging Therapeutics in Cardiovascular Pharmacology: A Focus on Personalized Antihypertensive Strategies. Clin Pharmacol Biopharm, 14: 571.

Copyright: © 2025 Farzaneh F. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 158
  • [From(publication date): 0-0 - Dec 08, 2025]
  • Breakdown by view type
  • HTML page views: 126
  • PDF downloads: 32
Top Connection closed successfully.